Showing results (291-300 of 447) with videos related to
Sort By:
Pageof 45
AI Zheng = Aizheng = Chinese Journal of Cancer|August 15, 2003
[Preliminary report of semimonthly 5-fluorouracil/leucovorin combined with paclitaxel in treatment of advanced gastric cancer (AGC)]Ning-Ning Zhou, Zhong-Mei Zhou, Mao-Zhen Liu, et al.Cancer|May 30, 2025
Tebotelimab plus niraparib in previously treated locally advanced or metastatic solid tumors: A phase 1b dose escalation and expansion studyMiao-Zhen Qiu, Hongming Pan, Ka On Lam, et al.Cancer Medicine|February 4, 2021
A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomyJie-Ying Liang, Hao-Cheng Lin, Jingwen Liu, et al.Journal of Medical Genetics|February 10, 2021
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panelWu Jiang, Lin Li, Chuan-Feng Ke, et al.Journal of Experimental & Clinical Cancer Research : CR|May 16, 2019
Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancerZhan-Hong Chen, Jing-Jing Qi, Qi-Nian Wu, et al.JAMA Oncology|May 5, 2022
Evaluation of Safety of Treatment With Anti-Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors: A Phase 1 Nonrandomized Clinical TrialMiao-Zhen Qiu, Yang Zhang, Ye Guo, et al.Cell Reports. Medicine|October 8, 2021
Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysisFeng Wang, Ming-Ming He, Yi-Chen Yao, et al.BMC Cancer|October 1, 2022
Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancerMing-Yu Lai, Shi-Yang Kang, Yu-Ting Sun, et al.Molecular Cancer|June 25, 2019
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinomaTing Li, Pei-Shan Hu, Zhixiang Zuo, et al.The Lancet. Gastroenterology & Hepatology|March 4, 2023
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 studyGong Chen, Ying Jin, Wen-Long Guan, et al.Pageof 45